2023
Evaluation of potential instruments for quantifying necrobiosis lipoidica severity via physician evaluation and patient-reported outcomes
Hashemi D, Nelson C, Nyberg M, Das M, Rosenbach M. Evaluation of potential instruments for quantifying necrobiosis lipoidica severity via physician evaluation and patient-reported outcomes. Journal Of The American Academy Of Dermatology 2023, 89: 1305-1306. PMID: 37633461, DOI: 10.1016/j.jaad.2023.08.048.Peer-Reviewed Original Research
2019
Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes
Hashemi DA, Brown-Joel ZO, Tkachenko E, Nelson CA, Noe MH, Imadojemu S, Vleugels RA, Mostaghimi A, Wanat KA, Rosenbach M. Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes. JAMA Dermatology 2019, 155: 455-459. PMID: 30785603, PMCID: PMC6523472, DOI: 10.1001/jamadermatol.2018.5635.Peer-Reviewed Original ResearchConceptsNecrobiosis lipoidicaClinical featuresThyroid diseaseDiagnosis of NLRare granulomatous conditionComorbidities of patientsMulticenter retrospective reviewElevated blood glucosePennsylvania Health SystemMassachusetts General HospitalNL lesionsNotable comorbiditiesMedical comorbiditiesMedian hemoglobinPatient demographicsMedian ageRetrospective reviewEpidemiologic characteristicsPathophysiologic characteristicsBiopsy statusGranulomatous conditionsCase reportFemale sexBlood glucoseRisk factors